San Diego, CA, United States of America

Raheleh Toughiri


 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Raheleh Toughiri: Innovator in Antibody Production

Introduction

Raheleh Toughiri is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of biochemistry and antibody production. With a total of 4 patents, she has made remarkable advancements in the development of innovative methods for producing antibodies.

Latest Patents

Toughiri's latest patents include groundbreaking methods for producing Fabs and bi-specific antibodies. These methods involve designed residues in the interfaces of the heavy chain-light chain variable (V/V) domain and the heavy chain-light chain constant (C/C) domain. Additionally, she has developed chemically-locked bispecific antibodies, which are formed through a process that ensures high specificity and homogeneity. This process utilizes bio-orthogonal click chemistry to create a chemically-locked bispecific IgG class antibody.

Career Highlights

Throughout her career, Raheleh Toughiri has worked with esteemed organizations such as Eli Lilly and Company and the University of North Carolina at Chapel Hill. Her work in these institutions has allowed her to further her research and contribute to the scientific community.

Collaborations

Toughiri has collaborated with notable colleagues, including Stephen John Demarest and Xiufeng Wu, enhancing her research through shared expertise and innovative ideas.

Conclusion

Raheleh Toughiri's contributions to the field of antibody production exemplify her dedication to innovation and scientific advancement. Her patents and collaborations reflect her commitment to improving biopharmaceutical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…